⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Gustave Roussy and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Gustave Roussy
↗Villejuif, France
Gustave Roussy is Europe's leading cancer center and a world-renowned institution for oncology care, research, and education. Located in Villejuif, France, it integrates patient treatment with high-impact translational research to accelerate the development of innovative cancer therapies.
The institute operates as a comprehensive cancer center, treating all types of cancer at every stage. It is a key player in the Paris-Saclay Cancer Cluster and collaborates extensively with industrial partners, techbio companies, and international research consortia like Cancer Core Europe to transform scientific discoveries into clinical practice.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1926
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Translational Research
Modalities:Small molecule, ADC, CAR-T
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:SOPHiA GENETICS (Genomic analysis), One Biosciences (Single-cell and AI-powered precision diagnostics), Cancer Core Europe (Consortium of cancer centers)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Laurence Albiges - Head of Medical Oncology
Benjamin Besse - Director of Clinical Research
LINKS
Website:gustaveroussy.fr
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Gustave Roussy. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.